Again I ask. Why was the only FDA ready to start P1 trial drug the company has, HemaXellerate, not moved forward? Why did BP have no interest in it? Why couldn't Lyin' Lander not find money for it?
Could it be no one wants to do business with a reprobate that Koos is?
Funny that almost all coins are worth more than RGBP stock. RGBP will soon be worth less than 1 cent if things continue as they do under Koos. He'll continue to dilute and that will continue to devalue the stock as he routinely does with all of his other stocks.
Koos is an incompetent businessman and CEO. His failures in being able to actually follow through on a plan explain why all of his companies are epic failures and why anyone investing in his companies ends up losing money unless you are friends and family who get ultra cheap shares to quickly sell for the fast profit.